1-2 of 2
Samuel Crawford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Outcomes Following Dose Modifications of First-Line Ibrutinib in Patients with Waldenström Macroglobulinemia

Shayna R Sarosiek, Gottfried R. von Keudell, Jonas Paludo, Monika Salkar, Barnabie Agatep, Anjali Franco, Samuel Crawford, Michelle Pacia, Jorge J. Castillo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3780.
https://doi.org/10.1182/blood-2023-181925
Published: 2023
Journal Articles

Early Adherence and Persistence to First-Line Ibrutinib or Acalabrutinib Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Atrial Fibrillation

Michael Fradley, Marie-Hélène Lafeuille, Bruno Emond, Samuel Crawford, Naijun Chen, Raisa Volodarsky, Jacqueline Nielsen, Bhavini Patel Srivastava
Journal: Blood
Blood (2022) 140 (Supplement 1): 10983–10984.
https://doi.org/10.1182/blood-2022-162797
Published: 2022